InvestorsHub Logo
Followers 40
Posts 1920
Boards Moderated 0
Alias Born 11/08/2011

Re: None

Wednesday, 02/27/2013 8:30:04 AM

Wednesday, February 27, 2013 8:30:04 AM

Post# of 963
Comments on the "news" release:

1. RBCC announces yet another "soon to be" joint venture with a yet to be named unknown privately held drug delivery company. The fact of the matter is that RBCC has yet to deliver on its first "joint venture" with AMBS announced months ago. Furthermore, it claims to have a joint venture with n3D when in fact it does not. This is just "more of the same" from Patrick Brown using a timed press release to coincide with the paid pump ongoing this week.

2. RBCC claims in the release to "help develop and market a revolutionary, sustained-release drug delivery platform". "Help develop and market"? How? RBCC has little to no cash and has absolutely no experience in the bioscience field. Once this unknown privately held drug delivery company scratches the surface on RBCC, it will be interesting to see what sort of "joint venture" evolves - if at all.

3. RBCC claims to hope to "sign a joint venture agreement to begin getting the new technology into doctors’ hands in the next few weeks" - really? That would be a change to actually execute an agreement!

4. How does RBCC intend to pay for the costs associated with this proposed Joint Venture? It is already obligated to purchase an equity stake in n3D with $5000 per week until the $250k is paid off. The Fish Farm division is only bringing in about $8000 per quarter in net revenues and the piggy bank is nearly empty with only $17k in cash. With a G&A burn rate of $813k and an interest expense burn rate of $206k over 9 months - the only option is to create some serious dilution to pay the bills.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.